Response to the Hammoud et al paper on ‘the new MTV generation’

The Hammoud paper published in this series is the first to explore PrEP use in the context of the sexualised use of drugs among MSM outside of a clinical trial setting. PrEP is extremely effective at preventing HIV during anal sex when using daily or event-based dosing regimens (Baeten et al., 2012; Grant et al., 2010; McCormack et al., 2016; Molina et al., 2015; Thigpen et al., 2012). Event-based dosing involves taking two tablets between 2 and 24  h before potential exposure, a third tablet 24 h later and a fourth 24 h after that, with daily dosing until at least two days after the last potential exposure.

Source: International Journal of Drug Policy - February 3, 2018 Category: Addiction Authors: Mitzy Gafos, Julie Chas, Gilles Pialoux Tags: Response Source Type: research